Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects

NCT03534648 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06865571 administered Day 7-14
DRUG: PF-06865571 administered Day 1-14
DRUG: PF-05221304 administered Day 1-14
DRUG: PF-05221304 administered Day 7-14

Sponsor

Pfizer